MedPath

ROLE OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN TREATING THE SYMPTOMS OF ENDOMETRIOSIS

Phase 2
Conditions
Health Condition 1: N80- Endometriosis
Registration Number
CTRI/2021/04/032599
Lead Sponsor
ational Institue of Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Female patient with a positive diagnostic finding for Endometriosis.

2.Reproductive age group (18-45 years)

3.Patients willing to give consent for participating in the study.

4.Patients who can read Bengali and/ Hindi and/English.

Exclusion Criteria

1.Pregnant women or lactating mothers.

2.Diagnosed cases of unstable psychiatric illness or other systemic disease affecting quality of life or some life threatening illness.

3.Patients not willing to participate in the study.

4.Substance abuse and/or dependence.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Numeric Rating Scale <br/ ><br>2. RAND Item 36 Health Survey 1.0 QuestionnaireTimepoint: Baseline and six months
Secondary Outcome Measures
NameTimeMethod
An attempt will be made to show changes in the pathology through lab investigations- USG/TVS and/laparoscopyTimepoint: baseline to six months
© Copyright 2025. All Rights Reserved by MedPath